mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |